Corbus Pharmaceuticals
CRBP
CRBP
122 hedge funds and large institutions have $103M invested in Corbus Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 50 increasing their positions, 33 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less funds holding
Funds holding: 140 → 122 (-18)
58% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 31
73% less capital invested
Capital invested by funds: $383M → $103M (-$280M)
Holders
122
Holding in Top 10
1
Calls
$11.7M
Puts
$11.1M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$2.05M | |
| 3 | +$1.34M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.14M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.1M |
Top Sellers
| 1 | -$31.7M | |
| 2 | -$12.6M | |
| 3 | -$10.6M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.82M |
| 5 |
Millennium Management
New York
|
-$4.03M |